ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Little Relation of Cancer Incidence To Known Carcinogens Except For Cigarettes, Holleb Says

July 14, 1978

Kennedy Bill Would Extend Cancer Program Three Years, Kill Budget Bypass

May 4, 1979

In Brief: Administration “Streamlining” Accomplished; DCCR contract Merit Review In Open Session

February 24, 1978

Funding opportunities listed.

June 11, 2004

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

Committee, BSC Recommend Against Continuing Women’s Health Trial; Appeal to NCAB Seen

January 15, 1988